EA200000419A1 - APPLICATION OF THIAZOLIDINDION FOR THE TREATMENT OF HYPERGLYCEMIA - Google Patents

APPLICATION OF THIAZOLIDINDION FOR THE TREATMENT OF HYPERGLYCEMIA

Info

Publication number
EA200000419A1
EA200000419A1 EA200000419A EA200000419A EA200000419A1 EA 200000419 A1 EA200000419 A1 EA 200000419A1 EA 200000419 A EA200000419 A EA 200000419A EA 200000419 A EA200000419 A EA 200000419A EA 200000419 A1 EA200000419 A1 EA 200000419A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hyperglycemia
application
thiazolidindion
treatment
mammal
Prior art date
Application number
EA200000419A
Other languages
Russian (ru)
Other versions
EA002659B1 (en
Inventor
Робин Эдвин Бакингэм
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000419A1 publication Critical patent/EA200000419A1/en
Publication of EA002659B1 publication Critical patent/EA002659B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Описывается способ лечения гипергликемии, при которой уровни глюкозы в плазме находятся в пределах от повышенных нормальных до ≤126 мг/дл; указанный способ включает введение эффективного нетоксичного и фармацевтически приемлемого количества инсулинового сенсибилизатора млекопитающему, которое в этом нуждается.Международная заявка была опубликована вместе с отчетом о международном поиске.A method of treating hyperglycemia is described, in which plasma glucose levels range from elevated normal to ≤126 mg / dL; This method involves the introduction of an effective non-toxic and pharmaceutically acceptable amount of insulin sensitizer to a mammal that needs it. The international application was published along with an international search report.

EA200000419A 1997-10-13 1998-10-12 Use 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)etoxy]benzyl]-thiazolidine-2,4-dione for treating hyperglycaemia EA002659B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (2)

Publication Number Publication Date
EA200000419A1 true EA200000419A1 (en) 2000-10-30
EA002659B1 EA002659B1 (en) 2002-08-29

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000419A EA002659B1 (en) 1997-10-13 1998-10-12 Use 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)etoxy]benzyl]-thiazolidine-2,4-dione for treating hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135513A0 (en) 2001-05-20
NO20001898L (en) 2000-06-09
SK5312000A3 (en) 2000-09-12
HUP0003922A2 (en) 2001-10-28
BG104404A (en) 2000-12-29
NZ503862A (en) 2003-01-31
OA11683A (en) 2005-01-12
TR200000958T2 (en) 2000-08-21
CA2306086A1 (en) 1999-04-22
CN1281359A (en) 2001-01-24
WO1999018943A1 (en) 1999-04-22
EA002659B1 (en) 2002-08-29
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
EP1023056A1 (en) 2000-08-02
BR9815219A (en) 2001-01-02
NO20001898D0 (en) 2000-04-12
JP2001519382A (en) 2001-10-23
AU9547098A (en) 1999-05-03
YU28800A (en) 2003-02-28
HUP0003922A3 (en) 2001-12-28
CZ20001297A3 (en) 2001-08-15
KR20010024481A (en) 2001-03-26
ID24521A (en) 2000-07-20
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
EA199900168A1 (en) APPLICATION OF GLP-1 OR HIS ANALOGUES IN THE TREATMENT OF MYOCARDIAL INFARCTION
EA200101089A1 (en) NEW METHOD OF TREATMENT
NO976063L (en) Procedure for the treatment of diabetes
EA200400149A1 (en) BENZOTIEPINES, possessing the activity of inhibitors of the displacement of bile acids in the podzvodushny gut and absorption of taurholy
NO970519D0 (en) Treatment of type II diabetes mellitus with amylin agonists
EA200001044A3 (en) Nep inhibitors for the treatment of female sexual disfunction
EA199800316A1 (en) SELECTIVE β-ADRENERGIC AGONISTS
EA200000748A1 (en) METHOD OF INTRODUCTION OF MONOMERIAL INSULIN ANALOGUES
AU6178198A (en) Method of treating a tumor
AU4385399A (en) Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
DE69617729D1 (en) USE OF ANTIMINERALCORTICOID COMPOUNDS AGAINST THE DRUG DEACTIVATION SYNDROME
CY1107745T1 (en) TREATMENT OF DIABETES WITH THIAZOLIDINODION AND SULFONYLURIA
EA200000042A1 (en) METHOD OF TREATING DIABETES BY ROSIGLITAZON AND INSULIN
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
EA200200502A1 (en) METHOD OF INTRODUCTION OF PHOSPHODYSTRASE 4 INHIBITOR
EA200000419A1 (en) APPLICATION OF THIAZOLIDINDION FOR THE TREATMENT OF HYPERGLYCEMIA
EA200000418A1 (en) APPLICATION OF THIAZOLIDINDION FOR THE TREATMENT OF HYPERGLYCEMIA
BR9810186A (en) Diabetes treatment with thiazolidinedione and alpha-glycosity inhibitor
BR9810292A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and alpha-glucosidase inhibitor
EA200000039A1 (en) TREATMENT OF DIABETES THIAZOLIDINDION AND SULPHONYL URIDE
EA199900006A1 (en) PREPARATION AND METHOD FOR THE TREATMENT OF STRONG HEART FAILURE
EA200100539A1 (en) NEW METHOD OF TREATMENT
EA199800822A1 (en) METHOD FOR TREATING EXCESSIVE AGGRESSION
EA200300222A1 (en) TREATMENT OF HEPATITIS C WITH THE HELP OF TYMOSIN, INTERFERON AND RIBAVIRIN
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU